Physician
Incare Health Solutions LLC
Incare Health Solutions LLC was paid $40.19M by Medicaid between Jan 2018 and Dec 2024, across 42 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 34% of everything it billed.
33Billing provider infoINCARE HEALTH SOLUTIONS LLC
MARION, OH 43302
MARION, OH 43302
33aNPI1235422403assigned 05/22/2011
33bProvider typeEmergency Medicine Physician
28Total paid$40.19M
24GClaims873,009
24DCodes billed42
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Medicine Physician providers in Ohio
Rank by total paid#2 of 368
Median peer was paid$13K
This provider vs. median3,117×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 82,168 | $3.45M | |
| 2019 | 92,863 | $3.90M | |
| 2020 | 99,003 | $3.91M | |
| 2021 | 159,171 | $6.73M | |
| 2022 | 115,770 | $4.83M | |
| 2023 | 96,033 | $3.59M | |
| 2024incomplete | 228,001 | $13.78M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 34% | 218,516 | 203,758 | $13.53M |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 27% | 146,208 | 132,005 | $10.82M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 16% | 115,736 | 111,543 | $6.40M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.2% | 74,478 | 67,733 | $3.29M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.3% | 84,000 | 79,828 | $2.12M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.7% | 26,477 | 25,350 | $1.88M |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.0% | 24,585 | 22,479 | $793K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 41,370 | 19,613 | $381K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 37,602 | 35,550 | $287K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 3,786 | 3,672 | $178K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 1,888 | 1,836 | $136K |
| 87428 | <1% | 10,607 | 8,756 | $132K |
30 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,563 | $80K |
| 81025 | <1% | 10,926 | $40K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,042 | $39K |
| 81002 | <1% | 24,342 | $34K | |
| 86328 | <1% | 894 | $16K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,934 | $9K |
| 99205 | Prolong outpt/office vis | <1% | 55 | $5K |
| A4250 | Urine test or reagent strips or tablets (100 tablets or strips) | <1% | 23,189 | $4K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 45 | $3K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,860 | $3K |
| 94664 | <1% | 646 | $2K | |
| 69210 | <1% | 137 | $2K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 133 | $1K |
| 81001 | <1% | 1,396 | $960.40 | |
| 90686 | <1% | 71 | $770.69 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,047 | $557.81 |
| 99201 | <1% | 14 | $538.40 | |
| 87070 | <1% | 102 | $511.43 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 70 | $340.20 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 677 | $284.76 |
| 94060 | <1% | 29 | $211.04 | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | <1% | 420 | $179.71 |
| 73610 | <1% | 13 | $126.47 | |
| 86308 | <1% | 14 | $63.96 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 1,645 | $38.83 |
| 99000 | <1% | 6,592 | $27.88 | |
| 94760 | <1% | 2,856 | $4.12 | |
| A4550 | Surgical trays | 0% | 13 | $0.00 |
| 3511F | 0% | 13 | $0.00 | |
| H0033 | Oral medication administration, direct observation | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHUSSAIN, MAZHAR (CEO)